表紙
市場調查報告書

全球骨髓移植市場:各治療類型,終端用戶,地區 - 市場規模,佔有率,預測,機會分析(2019年∼2027年)

Bone Marrow Transplant Market, By Treatment Type, By End User, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027

出版商 Coherent Market Insights 商品編碼 920724
出版日期 內容資訊 英文 220 Pages
商品交期: 2-3個工作天內
價格
Back to Top
全球骨髓移植市場:各治療類型,終端用戶,地區 - 市場規模,佔有率,預測,機會分析(2019年∼2027年) Bone Marrow Transplant Market, By Treatment Type, By End User, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027
出版日期: 2019年12月16日內容資訊: 英文 220 Pages
簡介

本報告提供全球骨髓移植市場的相關調查,市場機會,影響分析,成長及阻礙因素,各法規方案,治療類型、用途、地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 調查目的、前提條件

  • 調查目的
  • 前提條件
  • 簡稱

第2章 市場範圍

  • 報告的說明
    • 市場定義和範圍
  • 摘要整理
    • 各治療類型
    • 各終端用戶
    • 各地區
    • Coherent Opportunity Map (COM)

第3章 市場動態,法規,趨勢分析

  • 市場動態
    • 成長要素
    • 阻礙因素
    • 市場機會
  • 影響分析
  • 技術的進步
  • 主要的焦點
  • 流行病學
  • 法規方案
  • PEST分析
  • 合併和收購

第4章 市場分析:各治療類型

  • 概要
  • 白血病
  • 淋巴瘤
  • 骨髓瘤
  • 骨髓發育不良症候群
  • 骨髓增生性腫瘤
  • 再生不良性貧血
  • 固態腫瘤
  • 鐮狀細胞貧血症
  • 地中海型貧血
  • 其他

第5章 市場分析:各終端用戶

  • 概要
  • 醫院
  • 多專門診所
  • 門診病人手術中心
  • 市場規模、預測,與前一年同期比較的成長

第6章 市場分析:各地區

  • 概要
  • 北美
  • 南美
  • 歐洲
  • 亞太地區
  • 中東
  • 非洲

第7章 競爭情形

  • 企業簡介
    • Lonza Group Ltd.
    • Merck Millipore Corporation
    • Sanofi-Aventis LLC
    • AllCells LLC
    • STEMCELL Technologies
    • American Type Culture Collection (ATCC) Inc.

第8章 Section

  • 參照資料
  • 調查方法
  • 關於我們
目錄

Title:
Bone Marrow Transplant Market, By Treatment Type (Leukemia, Lymphoma, Myeloma, Myelodysplastic Syndrome, Myeloproliferative neoplasms, Aplastic Anemia, Solid Tumors, Sickle cell anemia, Thalassemia, Others), By End User (Hospitals, Multi-Specialty Clinics, Ambulatory Surgical Centers), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027.

Bone marrow transplant is the replacement of damaged cells with healthy stem cells and helps human body to produce optimum levels of white blood cells, platelets, or red blood cells to avoid infections, bleeding disorders, and others. Bone marrow constitutes of blood forming stem cells known as hematopoietic stem cells (HSCs). According to the Center for International Blood & Marrow Transplant Research (CIBMTR) reports 22,863 HCTs (Hematopoietic Cell Transplantation) performed in the U.S. in 2017

Key features of the study::

  • This report provides in-depth analysis of the Bone Marrow Transplant market and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2019-2027), considering 2018 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
  • It profiles key players in the global Bone Marrow Transplant market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include, Lonza Group Ltd., Merck Millipore Corporation, Sanofi-Aventis LLC, AllCells LLC, STEMCELL Technologies, and American Type Culture Collection (ATCC) Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global Bone Marrow Transplant market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Bone Marrow Transplant market

Detailed Segmentation::

  • None Marrow Transplant Market, By Treatment Type:
    • Leukemia
    • Lymphoma
    • Myeloma
    • Myelodysplastic Syndrome
    • Myeloproliferative neoplasms
    • Aplastic Anemia
    • Solid Tumors
    • Sickle cell anemia
    • Thalassemia
    • Others
  • None Marrow Transplant Market, By End User:
    • Hospitals
    • Multi-Specialty Clinics
    • Ambulatory Surgical Centers
  • None Marrow Transplant Market, By Region:
    • North America
      • By Treatment Type:
      • Leukemia
      • Lymphoma
      • Myeloma
      • Myelodysplastic Syndrome
      • Myeloproliferative neoplasms
      • Aplastic Anemia
      • Solid Tumors
      • Sickle cell anemia
      • Thalassemia
      • Others
      • By End User
      • Hospitals
      • Multi-Specialty Clinics
      • Ambulatory Surgical Centers
      • By Country:
      • U.S.
      • Canada
    • Latin America
      • By Treatment Type:
      • Leukemia
      • Lymphoma
      • Myeloma
      • Myelodysplastic Syndrome
      • Myeloproliferative neoplasms
      • Aplastic Anemia
      • Solid Tumors
      • Sickle cell anemia
      • Thalassemia
      • Others
      • By End User
      • Hospitals
      • Multi-Specialty Clinics
      • Ambulatory Surgical Centers
      • By Country:
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Europe
      • By Treatment Type:
      • Leukemia
      • Lymphoma
      • Myeloma
      • Myelodysplastic Syndrome
      • Myeloproliferative neoplasms
      • Aplastic Anemia
      • Solid Tumors
      • Sickle cell anemia
      • Thalassemia
      • Others
      • By End User
      • Hospitals
      • Multi-Specialty Clinics
      • Ambulatory Surgical Centers
      • By Country:
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
    • Asia Pacific
      • By Treatment Type:
      • Leukemia
      • Lymphoma
      • Myeloma
      • Myelodysplastic Syndrome
      • Myeloproliferative neoplasms
      • Aplastic Anemia
      • Solid Tumors
      • Sickle cell anemia
      • Thalassemia
      • Others
      • By End User
      • Hospitals
      • Multi-Specialty Clinics
      • Ambulatory Surgical Centers
      • By Country:
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • By Treatment Type:
      • Leukemia
      • Lymphoma
      • Myeloma
      • Myelodysplastic Syndrome
      • Myeloproliferative neoplasms
      • Aplastic Anemia
      • Solid Tumors
      • Sickle cell anemia
      • Thalassemia
      • Others
      • By End User
      • Hospitals
      • Multi-Specialty Clinics
      • Ambulatory Surgical Centers
      • By Country:
      • GCC
      • Israel
      • Rest of Middle East
    • Africa
      • By Treatment Type:
      • Leukemia
      • Lymphoma
      • Myeloma
      • Myelodysplastic Syndrome
      • Myeloproliferative neoplasms
      • Aplastic Anemia
      • Solid Tumors
      • Sickle cell anemia
      • Thalassemia
      • Others
      • By End User
      • Hospitals
      • Multi-Specialty Clinics
      • Ambulatory Surgical Centers
      • By Country:
      • South Africa
      • Central Africa
      • North Africa
  • Company Profiles
    • Lonza Group Ltd.*
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Merck Millipore Corporation
    • Sanofi-Aventis LLC
    • AllCells LLC
    • STEMCELL Technologies
    • American Type Culture Collection (ATCC) Inc.
  • "*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Treatment Type
    • Market Snippet, By Application
    • Market Snippet, By Region Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Technological Advancements
  • Key Highlights
  • Epidemiology
  • Regulatory Scenario
  • PEST Analysis
  • Mergers and Acquisitions

4. Global Bone Marrow Transplant Market, By Treatment Type, 2019 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2019 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017 - 2027
    • Segment Trends
  • Leukemia
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million and Number of Procedures)
  • Lymphoma
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million and Number of Procedures)
  • Myeloma
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million and Number of Procedures)
  • Myelodysplastic Syndrome
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million and Number of Procedures)
  • Myeloproliferative neoplasms
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million and Number of Procedures)
  • Aplastic Anemia
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million and Number of Procedures)
  • Solid Tumors
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million and Number of Procedures)
  • Sickle cell anemia
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million and Number of Procedures)
  • Thalassemia
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million and Number of Procedures)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Million and Number of Procedures

5. Global Bone Marrow Transplant Market, By End User, 2019 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2019 and 2027 (%)
    • Y-o-Y Growth Analysis, 2017 - 2027
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Multi-Specialty Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Ambulatory Surgical Centers
    • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)

6. Global Bone Marrow Transplant Market, By Region, 2019 - 2027, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2019 and 2027 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017-2026
  • North America
    • Market Size and Forecast, By Treatment Type, 2016 - 2027, (US$ Million and Number of Procedures)
    • Market Size and Forecast, By End User, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • U.S.
    • Canada
  • Latin America
    • Market Size and Forecast, By Treatment Type, 2016 - 2027, (US$ Million and Number of Procedures)
    • Market Size and Forecast, By End User, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Market Size and Forecast, By Treatment Type, 2016 - 2027, (US$ Million and Number of Procedures)
    • Market Size and Forecast, By End User, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Treatment Type, 2016 - 2027, (US$ Million and Number of Procedures)
    • Market Size and Forecast, By End User, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of APAC
  • Middle East
    • Market Size and Forecast, By Treatment Type, 2016 - 2027, (US$ Million and Number of Procedures)
    • Market Size and Forecast, By End User, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • Market Size and Forecast, By Treatment Type, 2016 - 2027, (US$ Million and Number of Procedures)
    • Market Size and Forecast, By End User, 2016 - 2027, (US$ Mn)
    • Market Size and Forecast, By Country, 2016 - 2027, (US$ Mn)
    • South Africa
    • Central Africa
    • North Africa

7. Competitive Landscape

  • Company Profiles
    • Lonza Group Ltd.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Merck Millipore Corporation
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • Sanofi-Aventis LLC
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • AllCells LLC
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • STEMCELL Technologies
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies
    • American Type Culture Collection (ATCC) Inc.
    • Company Overview
    • Product Portfolio
    • Financial Overview
    • Key Highlights
    • Market Strategies

8. Section

  • References
  • Research Methodology
  • About us and Sales Contact
Back to Top